An Intra-individual Titration Study of KRN1493 for the Treatment of Hypercalcemia in Patients With Parathyroid Carcinoma or Intractable Primary Hyperparathyroidism

NCT01460030 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Parathyroid Carcinoma
Hypercalcemia
Primary Hyperparathyroidism

Interventions

DRUG: Cinacalcet HCl

Sponsor

Kyowa Kirin Co., Ltd.